Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Takeda Pharmaceutical Co ADR (NYSE: TAK) closed the day trading at $13.44 down -0.37% from the previous closing price of $13.49. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 0.96 million shares were traded. TAK stock price reached its highest trading level at $13.47 during the session, while it also had its lowest trading level at $13.38.
Ratios:
For a better understanding of TAK, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.48. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.64.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when Giles Richard Platford bought 19,073 shares for $14.94 per share.
TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares of TAK for $29,999,994 on Jan 24 ’24. The 10% Owner now owns 3,755,583 shares after completing the transaction at $8.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 42609639424 and an Enterprise Value of 4772527079424. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.29, and their Forward P/E ratio for the next fiscal year is 28.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 1.05 whereas that against EBITDA is 3.592.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $15.08, while it has fallen to a 52-week low of $12.57. The 50-Day Moving Average of the stock is -4.35%, while the 200-Day Moving Average is calculated to be -3.19%.
Shares Statistics:
Over the past 3-months, TAK traded about 1.73M shares per day on average, while over the past 10 days, TAK traded about 2367690 shares per day. A total of 3.17B shares are outstanding, with a floating share count of 3.17B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.17% stake in the company. Shares short for TAK as of 1731628800 were 5661796 with a Short Ratio of 3.49, compared to 1728950400 on 7299215. Therefore, it implies a Short% of Shares Outstanding of 5661796 and a Short% of Float of 0.18000001.
Dividends & Splits
TAK’s forward annual dividend rate is 0.29, up from 192.0 a year ago. Against a Trailing Annual Dividend Yield of 14.232765The stock’s 5-year Average Dividend Yield is 4.7.
